-+ 0.00%
-+ 0.00%
-+ 0.00%

AMGEN: PHASE 3 OASIZ 303 STUDY OF DAZODALIBEP IN MODERATE-TO-SEVERE SYMPTOMATIC SJÖGREN’S DISEASE EXPECTED TO COMPLETE IN Q4 2026

路透·09/22/2026 13:00:00

请登录查看新闻详情